Ambu A/S (OTCMKTS:AMBBY) Shares Gap Up – Should You Buy?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) gapped up before the market opened on Wednesday. The stock had previously closed at $10.2250, but opened at $11.64. Ambu A/S shares last traded at $11.64, with a volume of 100 shares trading hands.

Wall Street Analyst Weigh In

Separately, UBS Group lowered Ambu A/S from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 15th. One equities research analyst has rated the stock with a Hold rating. According to data from MarketBeat, the company presently has a consensus rating of “Hold”.

Ambu A/S Price Performance

The stock’s fifty day moving average price is $10.85 and its 200-day moving average price is $10.38. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.77 and a quick ratio of 1.69. The firm has a market cap of $2.74 billion, a price-to-earnings ratio of 38.80 and a beta of 0.93.

Ambu A/S (OTCMKTS:AMBBY) last issued its quarterly earnings results on Tuesday, August 25th. The company reported $0.09 EPS for the quarter. Ambu A/S had a net margin of 8.18% and a return on equity of 8.49%. The business had revenue of $255.12 million during the quarter.

About Ambu A/S

Ambu A/S is a Danish medical device company that develops, manufactures and markets single-use products for hospitals, clinics and emergency care providers. Its portfolio includes disposable endoscopes and visualization systems used in areas such as bronchoscopy, gastrointestinal procedures, urology, ear, nose and throat care, and anesthesia.

The company also supplies products for airway management, patient monitoring and emergency care, including electrodes, resuscitation equipment and training manikins.